about
The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4aMutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening.Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genesEDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancerUV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasDeoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblastsGenome-wide association study identifies a new melanoma susceptibility locus at 1q21.3Genome-wide association study identifies three new melanoma susceptibility loci.Identification of a melanoma susceptibility locus and somatic mutation in TET2.Genome-wide association study identifies novel loci predisposing to cutaneous melanomaA variant in FTO shows association with melanoma risk not due to BMIEconomic evaluations of psychosocial interventions in cancer: a systematic review.Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.eMelanoBase: an online locus-specific variant database for familial melanoma.Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family StudyVAN: an R package for identifying biologically perturbed networks via differential variability analysisEvaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage ConsortiumLocalization of a novel melanoma susceptibility locus to 1p22A highly recurrent RPS27 5'UTR mutation in melanoma.Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk.Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma.The effect on melanoma risk of genes previously associated with telomere length.Skin cancer screening behaviours among individuals with a strong family history of malignant melanomaAnalysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.Loss-of-function fibroblast growth factor receptor-2 mutations in melanomaProtein signatures correspond to survival outcomes of AJCC stage III melanoma patients.Network-based biomarkers enhance classical approaches to prognostic gene expression signatures.Variation in the RAD51 gene and familial breast cancer.MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.Is there a role for genetic testing in patients with melanoma?MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family studyHistologic features of melanoma associated with CDKN2A genotype.Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanomaPrevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom.The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study.The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease.A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.Selection criteria for genetic assessment of patients with familial melanomaThe Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis
P50
Q24317334-5909D655-5264-4E18-AA0A-D8C8F71F21BFQ25257392-C9E89F9F-823B-4F68-9D48-380DCDDF8E23Q27314872-D1922169-2E7D-49C5-A44F-B66CCDCF9813Q27853201-870851D8-8C9E-4E55-80A5-D19EE92716B4Q28155972-1513C547-6518-4BAE-A40F-C5D5103856D5Q28270523-1C7AFB94-C67F-4AB1-A8F4-A6581D1A9587Q28361665-E668C743-B6E3-4B84-9C1C-9062B95E6283Q28943520-CB2D037D-4FE9-4EF7-B6D9-81C7403CF0DCQ29416994-B9C9CF49-3A96-4A79-9BD2-C4D4E608C216Q29417013-F616948B-78D5-4E66-A6E8-B1EEF14D1C70Q29417131-AC1C3192-6758-43F4-8CDD-54220E23AFBDQ29417157-490D9A84-4603-4E58-BCBA-B6B1A23C7125Q30251940-72D81A46-32D6-4D6D-B0AA-4BB6E86D4B60Q30403025-C52AD334-8890-47D8-9389-6584CFCC917EQ30877598-6E8EDC89-6BF3-4784-84E9-F060E5195EA7Q33566677-CCF1B611-F266-4DFF-8542-2F7442D4DD47Q33588662-AA02B9E0-620F-44E7-9A05-C2A2B78A3DFEQ33894527-EEDA0EBC-71D2-4475-B788-BB9A60812A19Q33905176-98C19FDA-B1EC-4A8E-B93F-78B685B004D2Q33917519-D3092855-2C02-4866-B722-36A9714D0CB5Q34047371-B89C216F-164B-47E6-B70B-D211D87EA85DQ34128569-729B59C3-F91F-4465-B8D0-37BECF7FB7BFQ34333988-1A72776B-93FA-47F6-B42D-725D3F4D61FEQ34344031-A1F9B764-7D30-47A9-81D5-F55E3609E989Q34480599-8D8CFE44-C2FD-4153-8CE5-24AC49F55C8BQ34520671-4CEB8B60-BC31-4BFF-BA6E-2C02D9A3AE29Q34842139-A85D59AE-6671-4F0F-8DAD-5D92D0096672Q34914017-E9061178-5A7B-4163-95CA-9203B5FAE251Q35012867-06D8D618-0E79-494B-A18C-EC33C60BB1A5Q35019782-B6AE8F15-9A9F-4EC2-A4C8-E239A2201618Q35071601-D6A11B45-D88B-4EE3-B287-5D088E06232BQ35088518-7D5DBC10-1B46-4A76-8519-8CA180A06B04Q35097007-B863BC1D-79AB-419F-AC20-24EDFF4D7934Q35102528-04B5E8ED-9C46-4BC2-812A-5315F0525744Q35180844-6BD74C98-EECE-4F39-968A-BB2B2239B314Q35659835-A4F9AF91-2796-4F9C-A212-75F4EB6106D6Q35689221-25232C5A-C388-46E2-935B-1C4AE11546E8Q35699278-9CF08643-8408-4752-B25D-49B8047A564FQ35840024-7419E5F6-552E-43ED-BDA8-12A368ED883DQ35947544-6E64B803-D51B-4E02-821A-761E1A09CBA4
P50
description
melanoma researcher
@en
onderzoeker
@nl
researcher
@en-gb
հետազոտող
@hy
name
Graham J Mann
@ast
Graham J Mann
@en
Graham J Mann
@en-gb
Graham J Mann
@es
Graham J Mann
@nl
Graham J Mann
@sl
type
label
Graham J Mann
@ast
Graham J Mann
@en
Graham J Mann
@en-gb
Graham J Mann
@es
Graham J Mann
@nl
Graham J Mann
@sl
altLabel
Graham Mann
@en
Mann GJ
@en
prefLabel
Graham J Mann
@ast
Graham J Mann
@en
Graham J Mann
@en-gb
Graham J Mann
@es
Graham J Mann
@nl
Graham J Mann
@sl
P108
P1053
G-4758-2014
P106
P1153
7201974520
P21
P31
P3829
P496
0000-0003-1301-405X